Results 51 to 60 of about 2,977,193 (214)

Dynamics of expression rates of growth factor proteins in psoriatic patients receiving a phototherapy

open access: yesVestnik Dermatologii i Venerologii, 2017
Goal. To study the dynamics of expression rates of growth factor proteins in psoriatic patients receiving the PUVA therapy. Materials and methods. The authors conducted a study of 30 patients with psoriasis vulgaris treated with the PUVA therapy.
V. V. Chikin   +3 more
doaj   +1 more source

Induction of Dramatic Hyperpigmentation in a Patient with Generalized Lichen Planus Treated with Re-PUVA

open access: yes, 2002
Background: Retinoids plus PUVA (re-PUVA) may be used in the treatment of lichen planus in cases that do not respond to monotherapy. Hyperpigmentation is a potential side effect of re-PUVA therapy.
Scott R. Florell   +2 more
core   +1 more source

PUVA-related punctate keratoses of the hands and feet

open access: yes
Background: We have observed, in patients undergoing high-dose PUVA treatment, a type of keratosis not previously described. The lesions usually occur on the sides of the palms or soles and are clinically distinct.
Turner RJ   +3 more
core   +5 more sources

Fototerapia na doença enxerto contra hospedeiro Phototherapy in the graft versus host disease

open access: yesAnais Brasileiros de Dermatologia, 2008
FUNDAMENTOS: A doença enxerto contra hospedeiro é um dos obstáculos ao sucesso do transplante de medula óssea, e o envolvimento cutâneo é freqüente.
Ida Duarte   +3 more
doaj   +1 more source

S1‐Leitlinie: Therapie der generalisierten pustulösen Psoriasis

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 11, Page 1669-1678, November 2026.
Zusammenfassung Die S1‐Leitlinie „Therapie der generalisierten pustulösen Psoriasis (GPP)“ ist eine deutsche Leitlinie, die nach den Kriterien der AWMF erstellt wurde. In der Langfassung werden Aspekte wie klinisches Bild, Pathogenese, Diagnose und Differenzialdiagnose, Begleiterkrankungen und Therapien beleuchtet.
Rotraut Mößner   +17 more
wiley   +1 more source

Fototerapija (UVB) i fotokemoterapija (PUVA) u liječenju psorijaze [PDF]

open access: yes, 2002
The review covers the current practice of phototherapy with ultraviolet (UV) radiation without sensitizers and of psoralen photochemotherapy (PUVA) in the treatment of psoriasis.
Kostović, Krešimir   +2 more
core  

PUVA-induced Bullous Pemphigoid in Psoriasis [PDF]

open access: yes, 2016
The association between psoriasis vulgaris and bullous pemphigoid is due to the still unclear autoimmune process. The common place of action is dermo-epidermal junction or basal membrane zone (BMZ) with specific alterations for both diseases ...
V'lckova Laskoska, Marija   +2 more
core   +1 more source

Combination therapy cyclosporin A--PUVA in psoriasis

open access: yesActa Dermato-Venereologica, 1990
No abstract available.
M J, Korstanje, R F, Hulsmans
openaire   +2 more sources

S1 Guideline: Therapy of generalized pustular psoriasis

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 11, Page 1669-1678, November 2026.
Summary The S1 guideline “Therapy of generalized pustular psoriasis (GPP)” is a German guideline developed in accordance with the criteria of the AWMF. The full version addresses clinical presentation, pathogenesis, diagnosis and differential diagnosis, comorbidities, and therapy.
Rotraut Mößner   +17 more
wiley   +1 more source

Efficacy, Safety, and Maintenance Use of Topical Bexarotene in Early‐Stage Mycosis Fungoides: A Single‐Center Retrospective Real‐World Study

open access: yesThe Journal of Dermatology, Volume 53, Issue 10, Page 1457-1464, October 2026.
ABSTRACT Topical bexarotene 1% gel is an approved skin‐directed treatment for refractory or persistent stage IA‐IB cutaneous T‐cell lymphoma, but real‐world evidence in mycosis fungoides (MF), particularly regarding maintenance use after complete response, remains limited.
Fatich Memet   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy